EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow‐Up

Akihito Takeuchi, Atsumasa Komori iD, Kazuhito Kawata iD, Osamu Yoshida iD, Kazunari Tanaka iD, Kazumichi Abe iD, Yukihisa Fujinaga iD, Tadashi Namisaki iD, Naruhiro Kimura, Tomohiro Katsumi, Ryo Miura, Naoko Tachizawa and 11 more

Hepatology Research · 2026-11 · 56 (11) · 1703-1712

DOI: 10.1111/hepr.70246 ↗

At a glance

Journal article in Hepatology Research, published online on 2026-07-17. Written by Akihito Takeuchi and 22 co-authors. Institution: Department of Medicine, Teikyo University, School of Medicine, Tokyo, Japan. 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ministry of Health, Labour and Welfare, Kowa Company, EA Pharma Co. Ltd..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Primary biliary cholangitis (PBC) frequently impairs health‐related quality of life (HRQOL); however, longitudinal changes in symptoms and their relationship with prognosis remain unclear. We aimed to elucidate the current status of symptoms and HRQOL in Japanese patients with PBC, evaluate 10‐year changes in PBC‐40 scores, and examine associations with long‐term outcomes.

Methods

This multicenter observational study comprised three analyses: (i) a 2025 cross‐sectional study assessing associations between clinical parameters, PBC‐40 (symptom indicators), and EQ‐5D‐5 L (HRQOL indicators); (ii) a longitudinal PBC‐40 study comparing scores from 2015 to 2025; and (iii) a longitudinal outcome study evaluating 2015 PBC‐40 scores and clinical parameters in relation to survival through 2025.

Results

In 2025%, 20%–50% of all patients ( n = 239) had moderate/severe PBC‐40 scores in each domain. EQ‐5D‐5L scores were significantly lower in women < 59 years versus general population, with multivariable analysis identifying itch, fatigue, and social domains as independent contributors to impaired HRQOL. Across a 10‐year follow‐up, overall significant deterioration was observed in symptoms ( p = 0.0015), itch ( p = 0.0039), and cognitive ( p = 0.0011) domains, while interindividual variability was greatest in itch and emotional and smallest in symptoms. In longitudinal outcome study ( n = 410), no PBC‐40 domain predicted death or liver transplantation.

Conclusions

HRQOL in patients with PBC was significantly impaired in younger female. Over 10 years, overall and interindividual changes in domain scores greatly varied, suggesting that symptom burdens are driven by heterogeneous underlying mechanisms. HRQOL impairment represents distinct dimensions of disease impact in PBC, independently of long‐term outcomes.

Subjects

Author keywords

EQ‐5D‐5 LHRQOLPBC‐40longitudinal analysisprognosis

Authors and institutions

  • Department of Medicine, Teikyo University, School of Medicine, Tokyo, Japan.
  • Clinical Research Center, National Hospital Organization NHO Nagasaki Medical Center, Nagasaki, Japan.
  • Hepatology Division, Department of Internal Medicine II, Hamamatsu University, School of Medicine, Shizuoka, Japan.
  • Department of Gastroenterology and Metabology, Ehime University Graduate, School of Medicine, Ehime, Japan.
  • Center for Gastroenterology, Teine-Keijinkai Hospital, Hokkaido, Japan.
  • Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.

ORCID profiles: Atsumasa Komori, Kazuhito Kawata, Osamu Yoshida, Kazunari Tanaka, Kazumichi Abe, Yukihisa Fujinaga, Tadashi Namisaki, Yoshinari Asaoka, Yoshiyuki Ueno, Shuji Terai, Hitoshi Yoshiji, Tadashi Ikegami, Akira Honda, Masanori Abe

Funding

  • Ministry of Health, Labour and Welfare
  • Kowa Company
  • EA Pharma Co. Ltd.
  • EA Pharma Co., Ltd.

Cite

APA

Takeuchi, A., Komori, A., Kawata, K., Yoshida, O., Tanaka, K., Abe, K., Fujinaga, Y., Namisaki, T., Kimura, N., Katsumi, T., Miura, R., Tachizawa, N., Asaoka, Y., Ueno, Y., Terai, S., Ohira, H., Yoshiji, H., Kikuchi, K., Matsui, T., …, & Tanaka, A. (2026). Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow‐Up. Hepatology Research, 56(11), 1703-1712. https://doi.org/10.1111/hepr.70246

Vancouver

Takeuchi A, Komori A, Kawata K, Yoshida O, Tanaka K, Abe K, et al. Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow‐Up. Hepatology Research. 2026;56(11):1703-1712. doi:10.1111/hepr.70246

BibTeX
@article{Takeuchi2026,
  author = {Takeuchi, Akihito and Komori, Atsumasa and Kawata, Kazuhito and Yoshida, Osamu and Tanaka, Kazunari and Abe, Kazumichi and Fujinaga, Yukihisa and Namisaki, Tadashi and Kimura, Naruhiro and Katsumi, Tomohiro and Miura, Ryo and Tachizawa, Naoko and Asaoka, Yoshinari and Ueno, Yoshiyuki and Terai, Shuji and Ohira, Hiromasa and Yoshiji, Hitoshi and Kikuchi, Kentaro and Matsui, Takeshi and Ikegami, Tadashi and Honda, Akira and Abe, Masanori and Tanaka, Atsushi},
  title = {Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow‐Up},
  journal = {Hepatology Research},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {1703--1712},
  doi = {10.1111/hepr.70246}
}
Start for free →